Dose dependent effects of O2/O3 therapy on PSA levels of patient with risk of prostate cancer

Type: Original paper       

Author:  David Pakula A.P., DOM


When used in effective concentrations and dosages, systemic O2/O3 treatment can potentially be used as a complementary therapy for prostate cancer patients electing disease management by active surveillance. Further study is warranted.

Link to paper